Clinical Trial Update: Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports that results for the Phase 1/2a trial of oral BAL101553 in adults with solid tumors, glioblastoma, and high-grade glioma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma
• Solid Tumors

Drugs mentioned

• BAL101553

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-26